Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui(Inserm), Frédéric FIORE(Canadian Partnership Against Cancer), Isabelle Iwanicki–Caron(Centre Hospitalier Universitaire de Rouen), Paul Basile(Inserm), Thierry Frébourg(Inserm), Claire Dolfus(Université de Rouen Normandie), Jean‐Jacques Tuech(Université de Rouen Normandie), Lilian Schwarz(Université de Rouen Normandie), Nasrin Sarafan‐Vasseur(Inserm), Marianne Paresy(Université de Rouen Normandie), Jean‐Christophe Sabourin(Inserm), Florian Clatot, Emmanuel Touré(Université de Rouen Normandie), Ludivine Beaussire(Inserm), Fabrice Jardin(Laboratoire National Henri Becquerel), Alice Gangloff(Centre Hospitalier Universitaire de Rouen), France Blanchard(Université de Rouen Normandie), Anne Perdrix(Inserm), Stéphane Lecleire(Inserm), Michel Antonietti(Université de Rouen Normandie), Pierre Michel(Aix-Marseille Université), Raied Alhameedi(Centre Hospitalier Universitaire de Rouen)
Cited by 122
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
|Genes & Development|1999|611
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520